1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb).
Saved in:
| Title: | 1558P Mitigating infusion-related reactions (IRRs) with cetirizine and montelukast in patients (pts) receiving REGN7075, an EGFR×CD28 bispecific antibody (bsAb). |
|---|---|
| Authors: | Segal, N.H.1 (AUTHOR), Girda, E.2 (AUTHOR), Keenan, B.P.3 (AUTHOR), Hecht, J.R.4 (AUTHOR), Le, X.5 (AUTHOR), Johnson, M.L.6 (AUTHOR), Torres Jimenez, J.7 (AUTHOR), Gomez-Roca, C.A.8 (AUTHOR), Ghiringhelli, F.9 (AUTHOR), Ates, O.10 (AUTHOR), Moreno Garcia, V.11 (AUTHOR), Laux, D.12 (AUTHOR), Berz, D.13 (AUTHOR), Chen, R.14 (AUTHOR), Wang, J.15 (AUTHOR), Han, H.15 (AUTHOR), Mathias, M.D.15 (AUTHOR), Seebach, F.A.15 (AUTHOR), Kinnaman, M.D.15 (AUTHOR), Sohal, D.16 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS930-S930. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.2188 |
